Αρχική World News Opinion: ‘We’re speaking with One Cancer Voice, but is anyone listening?’

Opinion: ‘We’re speaking with One Cancer Voice, but is anyone listening?’

NHS worker walking home.

Today we joined 46 other cancer charities to speak with One Cancer Voice on what we need from UK Governments and the NHS to plot a route out of the pandemic and towards world-leading cancer services.

Our statement is not about looking backwards. This is about recognising the herculean efforts of those on the front line and looking forwards. It’s about recognising the needs of people affected by cancer and those that care for them. It’s about setting out, collectively, what needs to happen to get our shared ambitions to beat cancer back on track.

The backlog of cancer cases, over 40,000 people across the UK who should have started cancer treatment in 2020, but did not, paints a dark picture. The majority of these are people who are living with cancer but don’t know it.

We know that an early diagnosis followed by swift treatment is the best way to increase your chances of surviving cancer. We know that the NHS has millions of people on its waiting lists. And we know that staff are overworked, anxious and exhausted. Together, this starkly illustrates why we urgently need a forward looking and fully funded plan to recover and transform how we tackle cancer across the UK.

As a community of cancer charities, backed by our supporters, we want to work with our 4 nation Governments and the NHS to make this plan a reality.

There are bright lights on the horizon that point to what might be possible.

Last week NHS England announced a colon capsule endoscopy pilot that is both bold and exciting. We need to harness and accelerate that kind of innovative thinking. One thing that stood out, amongst the challenge of the pandemic, was the way the NHS innovated, adapted and adopted new ways of working to meet patient need in extremely challenging circumstances. We need to hold onto that spirit if we are to clear the cancer backlog and transform cancer services, and if the UK Government is to deliver on its manifesto commitment to improve cancer survival in this country.

But spirit and can-do enthusiasm aren’t enough. As our joint statement sets out, we urgently need to see bold political will and leadership in this area. And dare we say, funding and certainty.

One Cancer Voice COVID-19 plan

It was disappointing that the recent Budget did not provide further assurance on how money allocated to clear the NHS backlog would support cancer patients. It was disappointing that the work of medical research charities, such as Cancer Research UK, who deliver the life-saving science and research that is being celebrated as a means through the pandemic is not being supported further at a time of significant loss in income. And it is hugely disappointing that we are still way off track on the NHS England Long Term Plan target of 3 in 4 cancers being diagnosed early by 2028 and to be smoke free by 2030.

We need action. As our joint statement sets out, decisions made now will determine whether we live up to the cancer ambitions set by the UK Governments, and drastically improve the lives of people affected by cancer. The time is now.

The cancer community stands ready to work with Governments across the UK to turn ambition into reality for all cancer patients.

Michelle Mitchell is Cancer Research UK’s chief executive

Tell us how you’re feeling about the situation facing cancer services, or your own experience of living with cancer during the pandemic.

Get involved

More on this topic



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Breast Cancer Survivor Invents Warming Bra Insert to Combat Cold Feeling of Breast Implants

In 2013, Kristen Carbone, of Providence, Rhode Island, had a preventative mastectomy to help protect herself against breast cancer after her mother died of...

FDA Approves Daratumumab plus Hyaluronidase-fihj, Carfilzomib, and Dexamethasone for Relapsed or Refractory Multiple Myeloma

On 30 November 2021, the US Food and Drug Administration (FDA) approved daratumumab plus hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) and carfilzomib (Kyprolis, Amgen,...

Thanks For Making This GivingTuesday Our Best One Yet!

We set ambitious goals for GivingTuesday, but they were driven by a time of great need. With your help, we hoped to provide food and...

Over 600 people in England set to benefit from innovative lung cancer treatment

<img width="620" height="348" src="https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero.jpg" class="attachment-featuredImage size-featuredImage" alt="Lung cancer cell" loading="lazy" srcset="https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero.jpg 620w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-300x168.jpg 300w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-220x123.jpg 220w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-150x84.jpg 150w" sizes="(max-width: 620px) 100vw, 620px" data-attachment-id="18781" data-permalink="https://news.cancerresearchuk.org/2020/09/11/targeted-drug-for-lung-cancer-approved-for-nhs-use-in-england/lung_cell_cropped-hero/"...

Touching a nerve: How neuroscience could advance our understanding of cancer

KTSDESIGN/SCIENCE PHOTO LIBRARY When supporters donate to our work, their combined generosity might lead to a new discovery that inches us closer to, for example,...

Nivolumab Demonstrates Clinical Benefits in a Statistically Evaluable Number of Patients with CUP

An investigator-initiated phase II study is the first to show that nivolumab has clinical activity with manageable toxicity in a statistically evaluable number of...